ISR
  • Home
  • About us
    • About ISR
    • Management
    • Board of Directors
  • Technology
    • Technology
    • Intellectual Property
    • Pipeline
  • Market
    • HIV
    • Cancer
    • HBV
  • Media room
    • Press releases
    • In media
    • Presentations and analysis
    • Video
    • Event calender
  • Investor Relations
    • Financial calender
    • Financial Reports
    • Corporate Governance
    • Largest shareholders
    • Certified Adviser
    • Share Issues
  • Contact
Immune System Regulation Immune System Regulation Immune System Regulation Immune System Regulation
  • Home
  • About us
    • About ISR
    • Management
    • Board of Directors
  • Technology
    • Technology
    • Intellectual Property
    • Pipeline
  • Market
    • HIV
    • Cancer
    • HBV
  • Media room
    • Press releases
    • In media
    • Presentations and analysis
    • Video
    • Event calender
  • Investor Relations
    • Financial calender
    • Financial Reports
    • Corporate Governance
    • Largest shareholders
    • Certified Adviser
    • Share Issues
  • Contact

Uncategorized

0
By ISR
In Uncategorized
Posted 27 March 2017

VD-intervju av BioStock

“I fredags börsnoterades ISR, ett immunterapibolag med rötter i Karolinska Institutet som utvecklar ett läkemedelskoncept för behandling av primär HIV-infektion och andra virusinfektioner [...]

READ MORE
Press releases
Recent Posts
  • Företrädesemission ger stadig ekonomisk bas för ISR Holding
  • Unik process för att behandla HIV
  • Analysis-post (test)
  • Se video-presentation om ISR på G&W Småbolagsfrukost LIVE!
  • Se video-presentation om ISR på G&W Småbolagsfrukost LIVE!
contact
ISR Immune System
Regulation Holding AB
Rörstrandsgatan 58
113 40 Stockholm, Sweden
Email: info@israb.se
Phone: +46 (0)705 42 79 39
© 2020 ISR Immune System Regulation Holding AB. All rights reserved.

Start typing and press Enter to search